Controlling the Introduction of New and Emerging Medical Technologies: Can We Meet the Challenge?

Wordsworth S , Donaldson C , Scott A Can We Afford the NHS? London: Institute for Public Policy Research, 1996.

Fuchs V The Health Economy. Harvard: Harvard University Press, 1986.

Newhouse JP . Medical care costs: how much welfare loss? J Economic Perspectives 1979;6: 3–21.

Harrison A , Dixon J , New B. Funding the NHS: Is the NHS sustainable? BMJ 1997; 314: 296–8.

Office of Technology Assessment. Development of Medical Technology Opportunities for Assessment. Washington DC: US Government Printing Office, 1976.

Standing Group on Health Technology. Assessing the Effects of Health Technologies: Principles, Practice, Proposals. London: Department of Health, 1992.

Stevens A , Robert G , Gabbay J. Identifying new health care technologies in the United Kingdom. Int J Tech Assess Health Care 1997; 13: 59–67.

Sheldon T , Faulkner A. Vetting new technologies. BMJ 1996; 313: 508.

Buxton M. Problems in the economic appraisal of new health technology: the evaluation of heart transplants in the UK. In: Stocking B ed. Economic Appraisal of Health Technology in the European Community. Oxford: Oxford University Press, 1987: 103–18.

Gelijns A , Rosenberg N. The dynamics of technological change in medicine. Health Affairs 1994; 13: 28–46.

Culyer A [Chairman]. Funding Research and Development in the NHS. London: HMSO, 1994.

NHSE. NHS Support for Non-commercial Externally Funded Research and Development. Wetherby: Health Publications Unit, 1996.

Dean M. Market squeeze on medical research. Lancet 1994; 344: 601.

NHSE. Responsibility for Meeting Patient Care Costs Associated with Research and Development in the NHS. Leeds: NHSE, 1997.

Gray S , Bevan G , Frankel S. Purchasing evidence: the corollary of evidence-based purchasing. J Publ Health Med 1997; 19: 6–10.

Coyle D Increasing the Impact of Economic Evaluations on Health-Care Decision-Making. York: University of York, 1993.

Sculpher M , Drummond M , Buxton M. The iterative use of economic evaluation as part of the process of health technology assessment. J Health Serv Res Policy 1997; 2: 26–30.

Battista R , Hodge M. The development of health care technology assessment: an international perspective. Int J Tech Ass Health Care 1995; 11: 287–300.

Luce B , Brown R. The use of technology assessment by hospitals, health maintenance organisations and third-party payers in the United States. Int J Tech Ass Health Care 1996; 11: 79–92.

Stocking B. Factors affecting the diffusion of three kinds of innovative medical technology in EC countries and in Sweden. In: Bos M ed. The Diffusion of Heart and Liver Transplantation across Europe. London: King's Fund, 1991.

Dixon J , Boyle S , Harrison A. Financial meltdown for the NHS? BMJ 1996; 312: 1432–3.

NHSE. Improving the Effectiveness of the NHS. Leeds: NHSE, 1994.

NHSE. New Drugs for Multiple Sclerosis. Leeds: NHSE, 1995.

NHSME. Contracting for Small and Specialist Services. Leeds: NHSME, 1993.

Clinical Standards Advisory Group. Specialised Services. London: HMSO, 1996.

Stevens A , Colin-Jones D , Gabbay J. Quick and clean: authoritative HTA for local health care contracting. Health Trends 1995; 27: 37–43.

Tomlinson J , Sutton J , McCabe C Tertiary Cardiology Guidance Notes for Purchasers, 1996/02. Trent Institute for Health Services Research; Universities of Leicester, Nottingham and Sheffield, 1997.

NHS Executive. Changing the Internal Market. Leeds: NHSE, 1997.

Rosen R , Mays N. The impact of the UK NHS purchaser–provider split on the ‘rational’ introduction of new medical technologies. Health Policy (in press).

Johns Hopkins Program for Medical Technology and Practice Assessment. Activity Report July 1992–June 1994. Baltimore: Johns Hopkins Medical Institutions, 1996.

Castaneda M , Breivis J. Technology assessment. Health Care Forum 1990; Nov-Dec: 101: 5.